Chemo Pharma Laboratories Receives Reclassification Request from Promoter Group Shareholder
Ms. Shanta Somani, a Promoter Group Shareholder of Chemo Pharma Laboratories Limited, has requested reclassification to the Public Shareholder category. The request, made on August 11, 2025, will be considered by the company's Board of Directors in an upcoming meeting. Managing Director Mr. Ruchit Mehta confirmed receipt of the request letter, and the company has assured compliance with all regulatory procedures.
31Jul 25
Chemo Pharma Laboratories Appoints New Statutory Auditor Amid Leadership Change
Chemo Pharma Laboratories Limited has announced a change in its statutory auditor. M/s Sanjay Rane & Associates LLP resigned citing pre-occupation with other assignments. The Board has recommended M/s. S S R V & Associates, Chartered Accountants, as the new statutory auditors, effective July 29, 2025, subject to shareholder approval. The new firm brings extensive experience in various financial areas. The transition complies with regulatory requirements, and no concerns were raised by the outgoing auditors.
24Jul 25
Chemo Pharma Laboratories' Statutory Auditors Resign Ahead of Term Completion
Sanjay Rane & Associates LLP, statutory auditors of Chemo Pharma Laboratories Limited, resigned effective July 23, 2025, citing pre-occupation with other assignments. This resignation comes nearly two years before their scheduled term completion. The auditors recently signed the FY 2024-25 audit report and assured no disputes with management or concerns about information suppression. Chemo Pharma has informed the Bombay Stock Exchange as per SEBI regulations but has not yet announced a replacement.
21Jul 25
Chemo Pharma Promoter Atibha Agriseeds Boosts Stake to 27.88% with Share Purchase
Atibha Agriseeds Private Limited, a promoter of Chemo Pharma Laboratories Ltd, has increased its stake in the company from 24.63% to 27.88%. The promoter acquired 48,781 equity shares (3.25% stake) through market purchases on the BSE for Rs 48.78 lakh on July 18, 2025. The transaction was disclosed to SEBI as per regulatory requirements. Ruchit Mehta holds positions in both companies, serving as Managing Director at Chemo Pharma and Director at Atibha Agriseeds.